Myeloid DLL4 Does Not Contribute to the Pathogenesis of Non-Alcoholic Steatohepatitis in Ldlr.sup.-/- Mice

Non-alcoholic steatohepatitis (NASH) is characterized by liver steatosis and inflammation. Currently, the underlying mechanisms leading to hepatic inflammation are not fully understood and consequently, therapeutic options are poor. Non-alcoholic steatohepatitis (NASH) and atherosclerosis share the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2016-11, Vol.11 (11), p.e0167199
Hauptverfasser: Jeurissen, Mike L. J, Walenbergh, Sofie M. A, Houben, Tom, Hendrikx, Tim, Li, Jieyi, Oligschlaeger, Yvonne, van Gorp, Patrick J, Gijbels, Marion J. J, Bitorina, Albert, Nessel, Isabell, Radtke, Freddy, Vooijs, Marc, Theys, Jan, Shiri-Sverdlov, Ronit
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 11
container_start_page e0167199
container_title PloS one
container_volume 11
creator Jeurissen, Mike L. J
Walenbergh, Sofie M. A
Houben, Tom
Hendrikx, Tim
Li, Jieyi
Oligschlaeger, Yvonne
van Gorp, Patrick J
Gijbels, Marion J. J
Bitorina, Albert
Nessel, Isabell
Radtke, Freddy
Vooijs, Marc
Theys, Jan
Shiri-Sverdlov, Ronit
description Non-alcoholic steatohepatitis (NASH) is characterized by liver steatosis and inflammation. Currently, the underlying mechanisms leading to hepatic inflammation are not fully understood and consequently, therapeutic options are poor. Non-alcoholic steatohepatitis (NASH) and atherosclerosis share the same etiology whereby macrophages play a key role in disease progression. Macrophage function can be modulated via activation of receptor-ligand binding of Notch signaling. Relevantly, global inhibition of Notch ligand Delta-Like Ligand-4 (DLL4) attenuates atherosclerosis by altering the macrophage-mediated inflammatory response. However, the specific contribution of macrophage DLL4 to hepatic inflammation is currently unknown. We hypothesized that myeloid DLL4 deficiency in low-density lipoprotein receptor knock-out (Ldlr.sup.-/-) mice reduces hepatic inflammation. Irradiated Ldlr.sup.-/- mice were transplanted (tp) with bone marrow from wild type (Wt) or DLL4.sup.f/f LysMCre.sup.+/0 (DLL4.sup.del) mice and fed either chow or high fat, high cholesterol (HFC) diet for 11 weeks. Additionally, gene expression was assessed in bone marrow-derived macrophages (BMDM) of DLL4.sup.f/f LysMCre.sup.WT and DLL4.sup.f/f LysMCre.sup.+/0 mice. In contrast to our hypothesis, inflammation was not decreased in HFC-fed DLL4.sup.del -transplanted mice. In line, in vitro, there was no difference in the expression of inflammatory genes between DLL4-deficient and wildtype bone marrow-derived macrophages. These results suggest that myeloid DLL4 deficiency does not contribute to hepatic inflammation in vivo. Since, macrophage-DLL4 expression in our model was not completely suppressed, it can't be totally excluded that complete DLL4 deletion in macrophages might lead to different results. Nevertheless, the contribution of non-myeloid Kupffer cells to notch signaling with regard to the pathogenesis of steatohepatitis is unknown and as such it is possible that, DLL4 on Kupffer cells promote the pathogenesis of steatohepatitis.
doi_str_mv 10.1371/journal.pone.0167199
format Article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A472218271</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A472218271</galeid><sourcerecordid>A472218271</sourcerecordid><originalsourceid>FETCH-LOGICAL-g1661-bd217e75c06ff432ba6185c52157bcd87b864aafd8ff3a9364d3a3472578be883</originalsourceid><addsrcrecordid>eNqN0M9LwzAUB_AiCs7pf-AhIAge2jVNm6THsflj0Dlx6nWk6UubkTWjSUH_ewt62MCDvMN7PD7fd3hBcI3jCBOGJ1vbd60w0d62EMWYMpznJ8EI5yQJaRKT04P5PLhwbhvHGeGUjoLt8guM1RWaF0WK5hYcerYezWzrO132HpC3yDeAXoRvbA0tOO2QVYNqw6mRtrFGS7T2ILxtYC-89gPQLSoq00Wu30fhJERLLeEyOFPCOLj67ePg_eH-bfYUFqvHxWxahDWmFIdllWAGLJMxVSolSSko5pnMEpyxUlaclZymQqiKK0VETmhaEUFSlmSMl8A5GQc3P3drYWCjW2V9J-ROO7mZDizBPGF4UNEfaqgKdloOj1R62B8F7o4Cg_Hw6WvRO7dZrF__b1cfx_b2wDYgjG-cNb3XtnWH8BtQkZNw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Myeloid DLL4 Does Not Contribute to the Pathogenesis of Non-Alcoholic Steatohepatitis in Ldlr.sup.-/- Mice</title><source>DOAJ Directory of Open Access Journals</source><source>Public Library of Science (PLoS)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Jeurissen, Mike L. J ; Walenbergh, Sofie M. A ; Houben, Tom ; Hendrikx, Tim ; Li, Jieyi ; Oligschlaeger, Yvonne ; van Gorp, Patrick J ; Gijbels, Marion J. J ; Bitorina, Albert ; Nessel, Isabell ; Radtke, Freddy ; Vooijs, Marc ; Theys, Jan ; Shiri-Sverdlov, Ronit</creator><creatorcontrib>Jeurissen, Mike L. J ; Walenbergh, Sofie M. A ; Houben, Tom ; Hendrikx, Tim ; Li, Jieyi ; Oligschlaeger, Yvonne ; van Gorp, Patrick J ; Gijbels, Marion J. J ; Bitorina, Albert ; Nessel, Isabell ; Radtke, Freddy ; Vooijs, Marc ; Theys, Jan ; Shiri-Sverdlov, Ronit</creatorcontrib><description>Non-alcoholic steatohepatitis (NASH) is characterized by liver steatosis and inflammation. Currently, the underlying mechanisms leading to hepatic inflammation are not fully understood and consequently, therapeutic options are poor. Non-alcoholic steatohepatitis (NASH) and atherosclerosis share the same etiology whereby macrophages play a key role in disease progression. Macrophage function can be modulated via activation of receptor-ligand binding of Notch signaling. Relevantly, global inhibition of Notch ligand Delta-Like Ligand-4 (DLL4) attenuates atherosclerosis by altering the macrophage-mediated inflammatory response. However, the specific contribution of macrophage DLL4 to hepatic inflammation is currently unknown. We hypothesized that myeloid DLL4 deficiency in low-density lipoprotein receptor knock-out (Ldlr.sup.-/-) mice reduces hepatic inflammation. Irradiated Ldlr.sup.-/- mice were transplanted (tp) with bone marrow from wild type (Wt) or DLL4.sup.f/f LysMCre.sup.+/0 (DLL4.sup.del) mice and fed either chow or high fat, high cholesterol (HFC) diet for 11 weeks. Additionally, gene expression was assessed in bone marrow-derived macrophages (BMDM) of DLL4.sup.f/f LysMCre.sup.WT and DLL4.sup.f/f LysMCre.sup.+/0 mice. In contrast to our hypothesis, inflammation was not decreased in HFC-fed DLL4.sup.del -transplanted mice. In line, in vitro, there was no difference in the expression of inflammatory genes between DLL4-deficient and wildtype bone marrow-derived macrophages. These results suggest that myeloid DLL4 deficiency does not contribute to hepatic inflammation in vivo. Since, macrophage-DLL4 expression in our model was not completely suppressed, it can't be totally excluded that complete DLL4 deletion in macrophages might lead to different results. Nevertheless, the contribution of non-myeloid Kupffer cells to notch signaling with regard to the pathogenesis of steatohepatitis is unknown and as such it is possible that, DLL4 on Kupffer cells promote the pathogenesis of steatohepatitis.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0167199</identifier><language>eng</language><publisher>Public Library of Science</publisher><subject>Analysis ; Complications and side effects ; Gene expression ; Genetic aspects ; Hepatitis ; Liver diseases ; Prevalence studies (Epidemiology) ; Risk factors</subject><ispartof>PloS one, 2016-11, Vol.11 (11), p.e0167199</ispartof><rights>COPYRIGHT 2016 Public Library of Science</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27924,27925</link.rule.ids></links><search><creatorcontrib>Jeurissen, Mike L. J</creatorcontrib><creatorcontrib>Walenbergh, Sofie M. A</creatorcontrib><creatorcontrib>Houben, Tom</creatorcontrib><creatorcontrib>Hendrikx, Tim</creatorcontrib><creatorcontrib>Li, Jieyi</creatorcontrib><creatorcontrib>Oligschlaeger, Yvonne</creatorcontrib><creatorcontrib>van Gorp, Patrick J</creatorcontrib><creatorcontrib>Gijbels, Marion J. J</creatorcontrib><creatorcontrib>Bitorina, Albert</creatorcontrib><creatorcontrib>Nessel, Isabell</creatorcontrib><creatorcontrib>Radtke, Freddy</creatorcontrib><creatorcontrib>Vooijs, Marc</creatorcontrib><creatorcontrib>Theys, Jan</creatorcontrib><creatorcontrib>Shiri-Sverdlov, Ronit</creatorcontrib><title>Myeloid DLL4 Does Not Contribute to the Pathogenesis of Non-Alcoholic Steatohepatitis in Ldlr.sup.-/- Mice</title><title>PloS one</title><description>Non-alcoholic steatohepatitis (NASH) is characterized by liver steatosis and inflammation. Currently, the underlying mechanisms leading to hepatic inflammation are not fully understood and consequently, therapeutic options are poor. Non-alcoholic steatohepatitis (NASH) and atherosclerosis share the same etiology whereby macrophages play a key role in disease progression. Macrophage function can be modulated via activation of receptor-ligand binding of Notch signaling. Relevantly, global inhibition of Notch ligand Delta-Like Ligand-4 (DLL4) attenuates atherosclerosis by altering the macrophage-mediated inflammatory response. However, the specific contribution of macrophage DLL4 to hepatic inflammation is currently unknown. We hypothesized that myeloid DLL4 deficiency in low-density lipoprotein receptor knock-out (Ldlr.sup.-/-) mice reduces hepatic inflammation. Irradiated Ldlr.sup.-/- mice were transplanted (tp) with bone marrow from wild type (Wt) or DLL4.sup.f/f LysMCre.sup.+/0 (DLL4.sup.del) mice and fed either chow or high fat, high cholesterol (HFC) diet for 11 weeks. Additionally, gene expression was assessed in bone marrow-derived macrophages (BMDM) of DLL4.sup.f/f LysMCre.sup.WT and DLL4.sup.f/f LysMCre.sup.+/0 mice. In contrast to our hypothesis, inflammation was not decreased in HFC-fed DLL4.sup.del -transplanted mice. In line, in vitro, there was no difference in the expression of inflammatory genes between DLL4-deficient and wildtype bone marrow-derived macrophages. These results suggest that myeloid DLL4 deficiency does not contribute to hepatic inflammation in vivo. Since, macrophage-DLL4 expression in our model was not completely suppressed, it can't be totally excluded that complete DLL4 deletion in macrophages might lead to different results. Nevertheless, the contribution of non-myeloid Kupffer cells to notch signaling with regard to the pathogenesis of steatohepatitis is unknown and as such it is possible that, DLL4 on Kupffer cells promote the pathogenesis of steatohepatitis.</description><subject>Analysis</subject><subject>Complications and side effects</subject><subject>Gene expression</subject><subject>Genetic aspects</subject><subject>Hepatitis</subject><subject>Liver diseases</subject><subject>Prevalence studies (Epidemiology)</subject><subject>Risk factors</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqN0M9LwzAUB_AiCs7pf-AhIAge2jVNm6THsflj0Dlx6nWk6UubkTWjSUH_ewt62MCDvMN7PD7fd3hBcI3jCBOGJ1vbd60w0d62EMWYMpznJ8EI5yQJaRKT04P5PLhwbhvHGeGUjoLt8guM1RWaF0WK5hYcerYezWzrO132HpC3yDeAXoRvbA0tOO2QVYNqw6mRtrFGS7T2ILxtYC-89gPQLSoq00Wu30fhJERLLeEyOFPCOLj67ePg_eH-bfYUFqvHxWxahDWmFIdllWAGLJMxVSolSSko5pnMEpyxUlaclZymQqiKK0VETmhaEUFSlmSMl8A5GQc3P3drYWCjW2V9J-ROO7mZDizBPGF4UNEfaqgKdloOj1R62B8F7o4Cg_Hw6WvRO7dZrF__b1cfx_b2wDYgjG-cNb3XtnWH8BtQkZNw</recordid><startdate>20161129</startdate><enddate>20161129</enddate><creator>Jeurissen, Mike L. J</creator><creator>Walenbergh, Sofie M. A</creator><creator>Houben, Tom</creator><creator>Hendrikx, Tim</creator><creator>Li, Jieyi</creator><creator>Oligschlaeger, Yvonne</creator><creator>van Gorp, Patrick J</creator><creator>Gijbels, Marion J. J</creator><creator>Bitorina, Albert</creator><creator>Nessel, Isabell</creator><creator>Radtke, Freddy</creator><creator>Vooijs, Marc</creator><creator>Theys, Jan</creator><creator>Shiri-Sverdlov, Ronit</creator><general>Public Library of Science</general><scope>IOV</scope><scope>ISR</scope></search><sort><creationdate>20161129</creationdate><title>Myeloid DLL4 Does Not Contribute to the Pathogenesis of Non-Alcoholic Steatohepatitis in Ldlr.sup.-/- Mice</title><author>Jeurissen, Mike L. J ; Walenbergh, Sofie M. A ; Houben, Tom ; Hendrikx, Tim ; Li, Jieyi ; Oligschlaeger, Yvonne ; van Gorp, Patrick J ; Gijbels, Marion J. J ; Bitorina, Albert ; Nessel, Isabell ; Radtke, Freddy ; Vooijs, Marc ; Theys, Jan ; Shiri-Sverdlov, Ronit</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g1661-bd217e75c06ff432ba6185c52157bcd87b864aafd8ff3a9364d3a3472578be883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Analysis</topic><topic>Complications and side effects</topic><topic>Gene expression</topic><topic>Genetic aspects</topic><topic>Hepatitis</topic><topic>Liver diseases</topic><topic>Prevalence studies (Epidemiology)</topic><topic>Risk factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jeurissen, Mike L. J</creatorcontrib><creatorcontrib>Walenbergh, Sofie M. A</creatorcontrib><creatorcontrib>Houben, Tom</creatorcontrib><creatorcontrib>Hendrikx, Tim</creatorcontrib><creatorcontrib>Li, Jieyi</creatorcontrib><creatorcontrib>Oligschlaeger, Yvonne</creatorcontrib><creatorcontrib>van Gorp, Patrick J</creatorcontrib><creatorcontrib>Gijbels, Marion J. J</creatorcontrib><creatorcontrib>Bitorina, Albert</creatorcontrib><creatorcontrib>Nessel, Isabell</creatorcontrib><creatorcontrib>Radtke, Freddy</creatorcontrib><creatorcontrib>Vooijs, Marc</creatorcontrib><creatorcontrib>Theys, Jan</creatorcontrib><creatorcontrib>Shiri-Sverdlov, Ronit</creatorcontrib><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jeurissen, Mike L. J</au><au>Walenbergh, Sofie M. A</au><au>Houben, Tom</au><au>Hendrikx, Tim</au><au>Li, Jieyi</au><au>Oligschlaeger, Yvonne</au><au>van Gorp, Patrick J</au><au>Gijbels, Marion J. J</au><au>Bitorina, Albert</au><au>Nessel, Isabell</au><au>Radtke, Freddy</au><au>Vooijs, Marc</au><au>Theys, Jan</au><au>Shiri-Sverdlov, Ronit</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Myeloid DLL4 Does Not Contribute to the Pathogenesis of Non-Alcoholic Steatohepatitis in Ldlr.sup.-/- Mice</atitle><jtitle>PloS one</jtitle><date>2016-11-29</date><risdate>2016</risdate><volume>11</volume><issue>11</issue><spage>e0167199</spage><pages>e0167199-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Non-alcoholic steatohepatitis (NASH) is characterized by liver steatosis and inflammation. Currently, the underlying mechanisms leading to hepatic inflammation are not fully understood and consequently, therapeutic options are poor. Non-alcoholic steatohepatitis (NASH) and atherosclerosis share the same etiology whereby macrophages play a key role in disease progression. Macrophage function can be modulated via activation of receptor-ligand binding of Notch signaling. Relevantly, global inhibition of Notch ligand Delta-Like Ligand-4 (DLL4) attenuates atherosclerosis by altering the macrophage-mediated inflammatory response. However, the specific contribution of macrophage DLL4 to hepatic inflammation is currently unknown. We hypothesized that myeloid DLL4 deficiency in low-density lipoprotein receptor knock-out (Ldlr.sup.-/-) mice reduces hepatic inflammation. Irradiated Ldlr.sup.-/- mice were transplanted (tp) with bone marrow from wild type (Wt) or DLL4.sup.f/f LysMCre.sup.+/0 (DLL4.sup.del) mice and fed either chow or high fat, high cholesterol (HFC) diet for 11 weeks. Additionally, gene expression was assessed in bone marrow-derived macrophages (BMDM) of DLL4.sup.f/f LysMCre.sup.WT and DLL4.sup.f/f LysMCre.sup.+/0 mice. In contrast to our hypothesis, inflammation was not decreased in HFC-fed DLL4.sup.del -transplanted mice. In line, in vitro, there was no difference in the expression of inflammatory genes between DLL4-deficient and wildtype bone marrow-derived macrophages. These results suggest that myeloid DLL4 deficiency does not contribute to hepatic inflammation in vivo. Since, macrophage-DLL4 expression in our model was not completely suppressed, it can't be totally excluded that complete DLL4 deletion in macrophages might lead to different results. Nevertheless, the contribution of non-myeloid Kupffer cells to notch signaling with regard to the pathogenesis of steatohepatitis is unknown and as such it is possible that, DLL4 on Kupffer cells promote the pathogenesis of steatohepatitis.</abstract><pub>Public Library of Science</pub><doi>10.1371/journal.pone.0167199</doi><tpages>e0167199</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2016-11, Vol.11 (11), p.e0167199
issn 1932-6203
1932-6203
language eng
recordid cdi_gale_infotracmisc_A472218271
source DOAJ Directory of Open Access Journals; Public Library of Science (PLoS); EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry
subjects Analysis
Complications and side effects
Gene expression
Genetic aspects
Hepatitis
Liver diseases
Prevalence studies (Epidemiology)
Risk factors
title Myeloid DLL4 Does Not Contribute to the Pathogenesis of Non-Alcoholic Steatohepatitis in Ldlr.sup.-/- Mice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T03%3A51%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Myeloid%20DLL4%20Does%20Not%20Contribute%20to%20the%20Pathogenesis%20of%20Non-Alcoholic%20Steatohepatitis%20in%20Ldlr.sup.-/-%20Mice&rft.jtitle=PloS%20one&rft.au=Jeurissen,%20Mike%20L.%20J&rft.date=2016-11-29&rft.volume=11&rft.issue=11&rft.spage=e0167199&rft.pages=e0167199-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0167199&rft_dat=%3Cgale%3EA472218271%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A472218271&rfr_iscdi=true